Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances

Summary

Regulations designed to prevent harm from substances like Psilocybin and Lysergic acid diethylamide severely cripple scientific progress. These rules make it nearly impossible to acquire illicit hallucinogens for vital research, achieving nothing but hindering potential life-saving discoveries. Reclassifying these compounds would unlock critical advancements in Pharmacology, impacting fields from Psychedelics and Drug Studies to Cannabis and Cannabinoid Research and even Forensic Toxicology and Drug Analysis. This regulatory business currently stifles crucial scientific inquiry.

Abstract

Modern day research, in an attempt to determine the potential therapeutic and adverse effects of illicit substances, is a growing field, but one that faces many regulatory challenges. Due to the potential abuse of illicit substances such as Cannabis, 3,4-methylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD) and psilocybin, regulations have been conceived with the intent of preventing harm and addiction. However, these regulations have also become a major barrier for the scientific community as they suffocate attempts of the scientists to acquire illicit substances for research purposes. Therefore, it is imperative to modify the current regulations of drug scheduling, leading to a reclassification of illicit substances that would allow for extensive testing in research settings. This reclassification effort could advance the potentially life-saving research of illicit substances.

Tags